Cargando…
A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods
SUMMARY: In a randomized, cross-over study, once monthly administration of vitamin D3 was preferred over a once daily administration of a fixed-dose combination of vitamin D3 and calcium, with a better compliance but without any significant difference in the increase in vitamin D levels. INTRODUCTIO...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656705/ https://www.ncbi.nlm.nih.gov/pubmed/26100413 http://dx.doi.org/10.1007/s00198-015-3205-z |
_version_ | 1782402273411858432 |
---|---|
author | Bruyère, O. Deroisy, R. Dardenne, N. Cavalier, E. Coffiner, M. Da Silva, S. De Niet, S. Reginster, J.-Y. |
author_facet | Bruyère, O. Deroisy, R. Dardenne, N. Cavalier, E. Coffiner, M. Da Silva, S. De Niet, S. Reginster, J.-Y. |
author_sort | Bruyère, O. |
collection | PubMed |
description | SUMMARY: In a randomized, cross-over study, once monthly administration of vitamin D3 was preferred over a once daily administration of a fixed-dose combination of vitamin D3 and calcium, with a better compliance but without any significant difference in the increase in vitamin D levels. INTRODUCTION: The aim of the present study was to compare a once-monthly administration of vitamin D3 to a daily administration of a fixed-dose combination of vitamin D3 and calcium during two treatment periods of 6 months. METHODS: One hundred volunteers aged 50 years old or older were randomized to receive either one drinkable ampoule containing 25,000 IU vitamin D3 (D-Cure®, SMB) once monthly (group VD) or one chewable tablet containing 1000 mg calcium carbonate + 800 IU vitamin D3 (Steovit Forte®, Takeda) once daily (group VDCa) during 6 months. After the first 6 months of treatment, the groups were reversed according to the randomized cross-over design. Treatment compliance (i.e. the primary outcome), preference, acceptability and vitamin D levels and adverse events were all collected. RESULTS: For the two periods, the patients had a significantly higher compliance in the VD group than in the VDCa group (p < 0.0001). During the study, 50 (56.8 %) patients preferred the VD treatment, 16 (18.2 %) patients preferred the VDCa, and for 22 (25.0 %) patients, neither treatment was preferred. At the end of the first 6 months of treatment, the mean (SD) increase of 25(OH)D was 6.57 ng/mL (8.19) in the VD group and 3.88 ng/mL (10.0) in the VDCa group (p = 0.16 between groups). CONCLUSION: In this study, a once-monthly administration of vitamin D3 was preferred over a once-daily administration of a fixed-dose combination of vitamin D3 and calcium, with a better compliance but without any significant difference in the increase in vitamin D levels. |
format | Online Article Text |
id | pubmed-4656705 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer London |
record_format | MEDLINE/PubMed |
spelling | pubmed-46567052015-12-01 A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods Bruyère, O. Deroisy, R. Dardenne, N. Cavalier, E. Coffiner, M. Da Silva, S. De Niet, S. Reginster, J.-Y. Osteoporos Int Original Article SUMMARY: In a randomized, cross-over study, once monthly administration of vitamin D3 was preferred over a once daily administration of a fixed-dose combination of vitamin D3 and calcium, with a better compliance but without any significant difference in the increase in vitamin D levels. INTRODUCTION: The aim of the present study was to compare a once-monthly administration of vitamin D3 to a daily administration of a fixed-dose combination of vitamin D3 and calcium during two treatment periods of 6 months. METHODS: One hundred volunteers aged 50 years old or older were randomized to receive either one drinkable ampoule containing 25,000 IU vitamin D3 (D-Cure®, SMB) once monthly (group VD) or one chewable tablet containing 1000 mg calcium carbonate + 800 IU vitamin D3 (Steovit Forte®, Takeda) once daily (group VDCa) during 6 months. After the first 6 months of treatment, the groups were reversed according to the randomized cross-over design. Treatment compliance (i.e. the primary outcome), preference, acceptability and vitamin D levels and adverse events were all collected. RESULTS: For the two periods, the patients had a significantly higher compliance in the VD group than in the VDCa group (p < 0.0001). During the study, 50 (56.8 %) patients preferred the VD treatment, 16 (18.2 %) patients preferred the VDCa, and for 22 (25.0 %) patients, neither treatment was preferred. At the end of the first 6 months of treatment, the mean (SD) increase of 25(OH)D was 6.57 ng/mL (8.19) in the VD group and 3.88 ng/mL (10.0) in the VDCa group (p = 0.16 between groups). CONCLUSION: In this study, a once-monthly administration of vitamin D3 was preferred over a once-daily administration of a fixed-dose combination of vitamin D3 and calcium, with a better compliance but without any significant difference in the increase in vitamin D levels. Springer London 2015-06-23 2015 /pmc/articles/PMC4656705/ /pubmed/26100413 http://dx.doi.org/10.1007/s00198-015-3205-z Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Bruyère, O. Deroisy, R. Dardenne, N. Cavalier, E. Coffiner, M. Da Silva, S. De Niet, S. Reginster, J.-Y. A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods |
title | A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods |
title_full | A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods |
title_fullStr | A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods |
title_full_unstemmed | A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods |
title_short | A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods |
title_sort | phase iv, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin d3 to compliance with daily administration of a fixed-dose combination of vitamin d3 and calcium during two 6-month periods |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656705/ https://www.ncbi.nlm.nih.gov/pubmed/26100413 http://dx.doi.org/10.1007/s00198-015-3205-z |
work_keys_str_mv | AT bruyereo aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods AT deroisyr aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods AT dardennen aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods AT cavaliere aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods AT coffinerm aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods AT dasilvas aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods AT deniets aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods AT reginsterjy aphaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods AT bruyereo phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods AT deroisyr phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods AT dardennen phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods AT cavaliere phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods AT coffinerm phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods AT dasilvas phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods AT deniets phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods AT reginsterjy phaseivtwoarmedrandomizedcrossoverstudycomparingcompliancewithonceamonthadministrationofvitamind3tocompliancewithdailyadministrationofafixeddosecombinationofvitamind3andcalciumduringtwo6monthperiods |